AbbVie
AbbVie's Analytical Development group within the Targeted LNP CMC Team is focused on developing advanced analytical methods for mRNA-lipid nanoparticle therapeutics. The group supports drug manufacturing, formulation, and quality assurance to ensure the safety and integrity of genetic medicines, collaborating with cross-functional teams and external partners.
Headquarters
North Chicago, Illinois, United States
Company Size
10001+ employees
Founded
2013
AbbVie is a biopharmaceutical company that develops and markets prescription medicines in areas including immunology, oncology, neuroscience, eye care, and aesthetics. It is the French website of AbbVie, the global pharmaceutical company formed as a spin-off from Abbott Laboratories.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AbbVie.
Principal Scientist II, Analytical Platform Sciences and Characterization, tLNP
AbbVie
Scientist I / II, Liquid Chromatography (LC), tLNP Analytical R&D
AbbVie
Sr. Scientist, Analytical R&D
MSD
Scientist / Engineer
Sanofi
Senior Scientist II, Analytical Development
AbbVie
Senior Scientist I/II, Analytical Development
AbbVie